These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

132 related articles for article (PubMed ID: 38821676)

  • 1. Genotoxicity assessments of N-nitrosoethylisopropylamine (NEIPA) and N-nitrosodiisopropylamine (NDIPA) in the C57BL/6J mouse.
    Ye Q; Geng X; Jiang H; Qin C; Wu H; Wang S; Wen H
    Mutat Res Genet Toxicol Environ Mutagen; 2024; 896():503763. PubMed ID: 38821676
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Genotoxicity evaluation of nitrosamine impurities using human TK6 cells transduced with cytochrome P450s.
    Li X; He X; Le Y; Guo X; Bryant MS; Atrakchi AH; McGovern TJ; Davis-Bruno KL; Keire DA; Heflich RH; Mei N
    Arch Toxicol; 2022 Nov; 96(11):3077-3089. PubMed ID: 35882637
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Genotoxicity assessment of eight nitrosamines using 2D and 3D HepaRG cell models.
    Seo JE; Yu JZ; Xu H; Li X; Atrakchi AH; McGovern TJ; Bruno KLD; Mei N; Heflich RH; Guo X
    Arch Toxicol; 2023 Oct; 97(10):2785-2798. PubMed ID: 37486449
    [TBL] [Abstract][Full Text] [Related]  

  • 4. N-nitrosamine impurity risk assessment in pharmaceuticals: Utilizing In vivo mutation relative potency comparison to establish an acceptable intake for NTTP.
    Powley MW; Sobol Z; Johnson GE; Clark RW; Dalby SM; Ykoruk BA; Galijatovic-Idrizbegovic A; Mowery MD; Escobar PA
    Regul Toxicol Pharmacol; 2024 Sep; 152():105681. PubMed ID: 39067806
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Prevention of genotoxic effects by dietary constituents in various organs of mice treated with nitrosamines.
    Knasmüller S; Huber W; Schulte-Hermann R
    Basic Life Sci; 1993; 61():447-57. PubMed ID: 8304952
    [No Abstract]   [Full Text] [Related]  

  • 6. High-Performance Liquid Chromatography-Tandem Mass Spectrometry Method Development and Validation for Simultaneous Determination of Seven Nitrosamine and Azidomethyl-Biphenyl-Tetrazole Impurities in Losartan.
    Luan NM; Khuyen VTK; Tuan ND
    J Sep Sci; 2024 Oct; 47(19):e202400277. PubMed ID: 39385440
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Are all nitrosamines concerning? A review of mutagenicity and carcinogenicity data.
    Thresher A; Foster R; Ponting DJ; Stalford SA; Tennant RE; Thomas R
    Regul Toxicol Pharmacol; 2020 Oct; 116():104749. PubMed ID: 32777431
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Mechanisms of Nitrosamine Mutagenicity and Their Relationship to Rodent Carcinogenic Potency.
    Snodin DJ; Trejo-Martin A; Ponting DJ; Smith GF; Czich A; Cross K; Custer L; Elloway J; Greene N; Kalgutkar AS; Stalford SA; Tennant RE; Vock E; Zalewski A; Ziegler V; Dobo KL
    Chem Res Toxicol; 2024 Feb; 37(2):181-198. PubMed ID: 38316048
    [TBL] [Abstract][Full Text] [Related]  

  • 9. A GC-MS/MS Method for Trace Level Quantification of Six Nitrosamine Impurities (NDMA, NDEA, NEIPA, NDIPA, NDPA, and NDBA) in Commercially Used Organic Solvents: Dichloromethane, Ethyl Acetate, Toluene, and O-xylene.
    Kosuri ER; Bhanti M; Jaywant MA; Han M; Wang X; Obeng M
    J Pharm Sci; 2023 May; 112(5):1225-1230. PubMed ID: 36462706
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Mutagenicity of alpha-hydroxy N-nitrosamines in V79 Chinese hamster cells.
    Mochizuki M; Osabe M; Anjo T; Suzuki E; Okada M
    J Cancer Res Clin Oncol; 1984; 108(3):290-5. PubMed ID: 6511803
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Rapid Quantitation of Four Nitrosamine Impurities in Angiotensin Receptor Blocker Drug Substances.
    Zhang J; Selaya SD; Shakleya D; Mohammad A; Faustino PJ
    J Pharm Sci; 2023 May; 112(5):1246-1254. PubMed ID: 36509171
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Determining recommended acceptable intake limits for N-nitrosamine impurities in pharmaceuticals: Development and application of the Carcinogenic Potency Categorization Approach (CPCA).
    Kruhlak NL; Schmidt M; Froetschl R; Graber S; Haas B; Horne I; Horne S; King ST; Koval IA; Kumaran G; Langenkamp A; McGovern TJ; Peryea T; Sanh A; Siqueira Ferreira A; van Aerts L; Vespa A; Whomsley R
    Regul Toxicol Pharmacol; 2024 Jun; 150():105640. PubMed ID: 38754805
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Ames test study designs for nitrosamine mutagenicity testing: qualitative and quantitative analysis of key assay parameters.
    Thomas DN; Wills JW; Tracey H; Baldwin SJ; Burman M; Williams AN; Harte DSG; Buckley RA; Lynch AM
    Mutagenesis; 2024 Mar; 39(2):78-95. PubMed ID: 38112628
    [TBL] [Abstract][Full Text] [Related]  

  • 14. An update on the current status and prospects of nitrosation pathways and possible root causes of nitrosamine formation in various pharmaceuticals.
    Wichitnithad W; Nantaphol S; Noppakhunsomboon K; Rojsitthisak P
    Saudi Pharm J; 2023 Feb; 31(2):295-311. PubMed ID: 36942272
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Carcinogenicity of methylated derivatives of N-nitrosodiethylamine and related compounds in Sprague-Dawley rats.
    Lijinsky W; Taylor HW
    J Natl Cancer Inst; 1979 Feb; 62(2):407-10. PubMed ID: 283272
    [TBL] [Abstract][Full Text] [Related]  

  • 16. A deep dive into historical Ames study data for N-nitrosamine compounds.
    Tennant RE; Ponting DJ; Thresher A
    Regul Toxicol Pharmacol; 2023 Sep; 143():105460. PubMed ID: 37495012
    [TBL] [Abstract][Full Text] [Related]  

  • 17. DNA adducts from N-nitrosodiethanolamine and related beta-oxidized nitrosamines in vivo: (32)P-postlabeling methods for glyoxal- and O(6)-hydroxyethyldeoxyguanosine adducts.
    Loeppky RN; Ye Q; Goelzer P; Chen Y
    Chem Res Toxicol; 2002 Apr; 15(4):470-82. PubMed ID: 11952332
    [TBL] [Abstract][Full Text] [Related]  

  • 18. 7-azabicyclo[2.2.1]heptane as a structural motif to block mutagenicity of nitrosamines.
    Ohwada T; Ishikawa S; Mine Y; Inami K; Yanagimoto T; Karaki F; Kabasawa Y; Otani Y; Mochizuki M
    Bioorg Med Chem; 2011 Apr; 19(8):2726-41. PubMed ID: 21435887
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Mutagenicity of N-alpha-acetoxyethyl-N-ethylnitrosamine and N,N-diethylnitrosamine in relation to the mechanisms of metabolic activation of dialkylnitrosamines.
    Fahmy OG; Fahmy MJ
    Cancer Res; 1976 Dec; 36(12):5404-12. PubMed ID: 826315
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Mutagenicity and synthesis of alpha-substituted N-nitrosamines: derivatives with dithiocarbamic acid.
    Pool BL; Bertram B; Wiessler M
    Carcinogenesis; 1982; 3(5):563-7. PubMed ID: 7046980
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 7.